1. Rengo M, Caruso D, De Cecco CN, Lucchesi P, Bellini D, Ma-ceroni MM, et al. High concentration (400 mgI/mL) versus low concentration (320 mgI/mL) iodinated contrast media in multi detector computed tomography of the liver: a randomized, single centre, noninferiority study. Eur J Radiol. 2012; 81:3096–3101.
2. Rengo M, Bellini D, De Cecco CN, Osimani M, Vecchietti F, Caruso D, et al. The optimal contrast media policy in CT of the liver. Part II: clinical protocols. Acta Radiol. 2011; 52:473–480.
Article
3. Laghi A. Multidetector CT (64 slices) of the liver: examination techniques. Eur Radiol. 2007; 17:675–683.
Article
4. Marchianò A, Spreafico C, Lanocita R, Frigerio L, Di Tolla G, Patelli G, et al. Does iodine concentration affect the diagnostic efficacy of biphasic spiral CT in patients with hepatocellular carcinoma? Abdom Imaging. 2005; 30:274–280.
Article
5. Kondo H, Kanematsu M, Goshima S, Tomita Y, Kim MJ, Moriyama N, et al. Body size indexes for optimizing iodine dose for aortic and hepatic enhancement at multidetector CT: comparison of total body weight, lean body weight, and blood volume. Radiology. 2010; 254:163–169.
Article
6. Kondo H, Kanematsu M, Goshima S, Watanabe H, Onozuka M, Moriyama N, et al. Aortic and hepatic enhancement at multidetector CT: evaluation of optimal iodine dose deter-mined by lean body weight. Eur J Radiol. 2011; 80:e273–e277.
Article
7. Yanaga Y, Awai K, Nakaura T, Namimoto T, Oda S, Funama Y, et al. Optimal contrast dose for depiction of hypervas-cular hepatocellular carcinoma at dynamic CT using 64-MDCT. AJR Am J Roentgenol. 2008; 190:1003–1009.
Article
8. Fleischmann D. Multiple detector-row CT angiography of the renal and mesenteric vessels. Eur J Radiol. 2003; 45(Suppl 1):S79–S87.
Article
9. Johnson PT, Fishman EK. IV contrast selection for MDCT: current thoughts and practice. AJR Am J Roentgenol. 2006; 186:406–415.
Article
10. Loewe C, Becker CR, Berletti R, Cametti CA, Caudron J, Cou-dyzer W, et al. 64-Slice CT angiography of the abdominal aorta and abdominal arteries: comparison of the diagnostic efficacy of iobitridol 350 mgI/mL versus iomeprol 400 mgI/mL in a prospective, randomised, double-blind multi-centre trial. Eur Radiol. 2010; 20:572–583.
11. Katzberg RW, Barrett BJ. Risk of iodinated contrast material–induced nephropathy with intravenous administration. Radiology. 2007; 243:622–628.
12. Thomsen HS, Morcos SK, Barrett BJ. Contrast-induced ne-phropathy: the wheel has turned 360 degrees. Acta Radiol. 2008; 49:646–657.
Article
13. Nyman U, Almén T, Aspelin P, Hellström M, Kristiansson M, Sterner G. Contrast-medium-Induced nephropathy corre-lated to the ratio between dose in gram iodine and esti-mated GFR in mL/min. Acta Radiol. 2005; 46:830–842.
Article
14. Lim A, O'Neil B, Heilbrun ME, Dechet C, Lowrance WT. The contemporary role of renal mass biopsy in the management of small renal tumors. Front Oncol. 2012; 2:106.
Article
15. Lee CT, Katz J, Shi W, Thaler HT, Reuter VE, Russo P. Surgical management of renal tumors 4 cm. Or less in a contemporary cohort. J Urol. 2000; 163:730–736.
Article
16. Nguyen MM, Gill IS, Ellison LM. The evolving presentation of renal carcinoma in the United States: trends from the surveillance, epidemiology, and end results program. J Urol. 2006; 176(6 Pt 1):2397–2400. discussion. 2400.
Article
17. Alasker A, Williams SK, Ghavamian R. Small renal mass: to treat or not to treat. Curr Urol Rep. 2013; 14:13–18.
Article
18. Sandstede JJ, Kaupert C, Roth A, Jenett M, Harz C, Hahn D. Comparison of different iodine concentrations for multidetector row computed tomography angiography of segmen-tal renal arteries. Eur Radiol. 2005; 15:1211–1214.
Article
19. Sandstede JJ, Werner A, Kaupert C, Roth A, Jenett M, Harz C, et al. A prospective study comparing different iodine concentrations for triphasic multidetector row CT of the upper abdomen. Eur J Radiol. 2006; 60:95–99.
Article
20. Kaufman L, Kramer DM, Crooks LE, Ortendahl DA. Measur-ing signal-to-noise ratios in MR imaging. Radiology. 1989; 173:265–267.
Article
21. Firbank MJ, Coulthard A, Harrison RM, Williams ED. A comparison of two methods for measuring the signal to noise ratio on MR images. Phys Med Biol. 1999; 44:N261–N264.
Article
22. Magnotta VA, Friedman L. FIRST BIRN. Measurement of signal-to-noise and contrast-to-noise in the fBIRN multicenter imaging study. J Digit Imaging. 2006; 19:140–147.
Article
23. Setty BN, Sahani DV, Ouellette-Piazzo K, Hahn PF, Shepard JA. Comparison of enhancement, image quality, cost, and adverse reactions using 2 different contrast medium concentrations for routine chest CT on 16-slice MDCT. J Comput Assist Tomogr. 2006; 30:818–822.
Article
24. Holalkere NS, Matthes K, Kalva SP, Brugge WR, Sahani DV. 64-slice multidetector row CT angiography of the abdomen: comparison of low versus high concentration iodinated contrast media in a porcine model. Br J Radiol. 2011; 84:221–228.
Article
25. Kundel HL, Polansky M. Measurement of observer agree-ment. Radiology. 2003; 228:303–308.
Article
26. Bae KT. Optimization of contrast enhancement in thoracic MDCT. Radiol Clin North Am. 2010; 48:9–29.
Article
27. Schoellnast H, Brader P, Oberdabernig B, Pisail B, Deut-schmann HA, Fritz GA, et al. High-concentration contrast media in multiphasic abdominal multidetector-row computed tomography: effect of increased iodine flow rate on parenchymal and vascular enhancement. J Comput Assist Tomogr. 2005; 29:582–587.
28. Berland LL, Lee JY. Comparison of contrast media injection rates and volumes for hepatic dynamic incremented computed tomography. Invest Radiol. 1988; 23:918–922.
Article
29. Chambers TP, Baron RL, Lush RM. Hepatic CT enhancement. Part I. Alterations in the volume of contrast material within the same patients. Radiology. 1994; 193:513–517.
Article
30. Dean PB, Violante MR, Mahoney JA. Hepatic CT contrast enhancement: effect of dose, duration of infusion, and time elapsed following infusion. Invest Radiol. 1980; 15:158–161.
Article
31. Heiken JP, Brink JA, McClennan BL, Sagel SS, Crowe TM, Gaines MV. Dynamic incremental CT: effect of volume and concentration of contrast material and patient weight on hepatic enhancement. Radiology. 1995; 195:353–357.
Article
32. Heiken JP, Brink JA, McClennan BL, Sagel SS, Forman HP, DiCroce J. Dynamic contrast-enhanced CT of the liver: comparison of contrast medium injection rates and uniphasic and biphasic injection protocols. Radiology. 1993; 187:327–331.
Article
33. Ramgren B, Björkman-Burtscher IM, Holtås S, Siemund R. CT angiography of intracranial arterial vessels: impact of tube voltage and contrast media concentration on image quality. Acta Radiol. 2012; 53:929–934.
Article
34. Bagrodia A, Darwish OM, Rapoport Y, Margulis V. Risk pre-diction in the management of small renal masses. Curr Opin Urol. 2012; 22:347–352.
Article
35. Gill IS, Aron M, Gervais DA, Jewett MA. Clinical practice. Small renal mass. N Engl J Med. 2010; 362:624–634.
36. Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA. The natural history of incidentally detected small renal masses. Cancer. 2004; 100:738–745.
Article